Point72 Asia »

Kinnate Biopharma shares owned by Point72 Asia

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Point72 Asia from 13F filings

Historical chart of Point72 Asia investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Point72 Asia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Point72 Asia

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2k 2.2k 2.37

More positions owned by Point72 Asia

Chevron Corporation (CVX)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Williams Companies (WMB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Crescent Point Energy Trust (CPG)
Enerplus Corp (ERF)
Chord Energy Corporation Com New (CHRD)
Imperial Oil Com New (IMO)
Sunrun (RUN)
Jinkosolar Hldg Sponsored Adr (JKS)
Fortis (FTS)
ConocoPhillips (COP)
Pembina Pipeline Corp (PBA)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)

View all positions for Point72 Asia

Top funds holding Kinnate Biopharma

OrbiMed Advisors
Tang Capital Management
Lynx1 Capital Management
Viking Global Investors
Vanguard Group
Deltec Asset Management
Millennium Management
BML Capital Management
Citadel Advisors
GSA Capital Partners
Two Sigma Investments
Acuitas Investments
Equitec Proprietary Markets
Marshall Wace
Goldman Sachs Group

View all funds holding Kinnate Biopharma